On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
On Apr. 9, 2020, Laurent Pharmaceuticals announced that a spin off from McGill University planned to test its…
On Apr. 9, 2020, Codex DNA announced a newly developed and released suite of products and services designed…
On Apr. 9, 2020, BioSig Technologies announced that an article titled “The IMPDH inhibitor merimepodib suppresses SARS-COV-2 replications”…
On Apr. 9, 2020, Washington University School of Medicine in St. Louis launched a clinical trial for patients…
On Apr. 9, 2020, LabCorp and Ciox Health announced an agreement to collaborate on a comprehensive U.S.-based COVID-19…
On Apr. 9, 2020, BioCryst Pharmaceuticals announced the company has opened enrollment into a randomized, double-blind, placebo-controlled clinical…
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
On Apr. 9, 2020, Chembio Diagnostics has been selected for use in a Stony Brook Medicine effort to…
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
On Apr. 8, 2020, Abbott announced that the FreeStyle Libre 14 day system, a continuous glucose monitoring (CGM)…
On Apr. 8, 2020, TGen, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern…
On Apr. 8, 2020, Gilead Sciences announced the creation of the global Gilead CARES (COVID-19 Acute Relief and…
On Apr. 8, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the FDA for…
On Apr. 8, 2020, Mateon Therapeutics announced that its COVID-19 directed antiviral screening program discovered that Artemisinin is…
![Dynavax donated 10,000 doses of HEPLISAV-Bﾮ [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
On Apr. 8, 2020, MediciNova announced that it had initiated a clinical trial of MN-166 (ibudilast) for acute…
On Apr. 8, 2020, PharmaCyte Biotech announced a license agreement with Hai Kang Life Corp. whereby PharmaCyte received…
On Apr. 8, 2020, Nanomix announced that the company had been awarded $570,000 in funding from Biomedical Advanced…
On Apr. 8, 2020, Vanda Pharmaceuticals and the University of Illinois at Chicago (UIC) announced a research partnership…
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
On Apr. 8, 2020, CSL Behring and SAB Biotherapeutics announced a partnership to combat the coronavirus pandemic with…
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…
On Apr. 8, 2020, Philips announced that the U.S. Government and Philips agreed to team up to increase…
On Apr. 7, 2020, Karyopharm Therapeutics announced plans to initiate a global randomized clinical trial for low dose…
On Apr. 7, 2020, a map of interactions between the novel coronavirus and human proteins is helping scientists…
On Apr. 7, 2020, Pluristem Therapeutics announced preliminary data from its compassionate use program, treating seven patients suffering…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On Apr. 7, 2020, Cumberland Pharma announced an initiative to increase availability of Vaprisol (conivaptan hydrochloride) injection for…
On Apr. 7, 2020, Mesa Biotech announced it was shipping 10,000 of its Accula SARS-CoV-2 molecular rapid point…